Stacey J. Adam
Foundation for the National Institutes of Health · 79 works · 2,345 citations · h-index 26
Top works
- Divergent Roles for RalA and RalB in Malignant Growth of Human Pancreatic Carcinoma Cells
- Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
- MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism
- Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19
- Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19
- A Network of Genetic Events Sufficient to Convert Normal Human Cells to a Tumorigenic State
- Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol
- Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19
- The Integration of Clinical Trials With the Practice of Medicine
- The NIH-led research response to COVID-19
- Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics
- Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels
- Twist1 Suppresses Senescence Programs and Thereby Accelerates and Maintains Mutant Kras-Induced Lung Tumorigenesis
- Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia
- Genetic induction of tumorigenesis in Swine
- Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration
- Defining the Cooperative Genetic Changes That Temporally Drive Alveolar Rhabdomyosarcoma
- Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction
- The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
- Challenges to Using Big Data in Cancer